Aug 08, 2024 / 09:00PM GMT
Operator
Good day, and thank you for standing by. welcome to the Coherus BioSciencesâ second quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speakerâs presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that todayâs conference is being recorded.
I would now like to hand the conference over to Jami Taylor, Head of Investor Relations. Please go ahead.
Jami Taylor - Coherus BioSciences In - Head of Investor Relations
Thank you, operator. Good afternoon, and welcome to Coherus BioSciencesâ second quarter 2024 earnings conference call. Joining me today to discuss our results are Denny Lanfear, Chief Executive Officer of Coherus; Bryan McMichael, Chief Financial Officer; Paul Reider, Chief Commercial Officer; Dr. Rosh Dias, Chief Medical Officer; and Dr. Theresa LaVallee, Chief Development Officer.
Before we get started, I would like to remind you that todayâs call includes forward-looking statements regarding Coherusâ current expectations about future
Q2 2024 Coherus BioSciences Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot